QM/MM refinement and analysis of protein bound retinoic acid

Retinoic acid (RA) is a vitamin A derivative, which modifies the appearance of fine wrinkles and roughness of facial skin and treats acne and activates gene transcription by binding to heterodimers of the retinoic acid receptor (RAR) and the retinoic X receptor (RXR). There are series of protein bound RA complexes available in the protein databank (PDB), which provides a broad range of information about the different bioactive conformations of RA. To gain further insights into the observed bioactive RA conformations we applied quantum mechanic (QM)/molecular mechanic (MM) approaches to re‐refine the available RA protein‐ligand complexes. MP2 complete basis set (CBS) extrapolations single energy calculations are also carried out for both the experimental conformations and QM optimized geometries of RA in the gas as well as solution phase. The results demonstrate that the re‐refined structures show better geometries for RA than seen in the originally deposited PDB structures through the use of QMs for the ligand in the X‐ray refinement procedure. QM/MM re‐refined conformations also reduced the computed strain energies found in the deposited crystal conformations for RA. Finally, the dependence of ligand strain on resolution is analyzed. It is shown that ligand strain is not converged in our calculations and is likely an artifact of the typical resolutions employed to study protein‐ligand complexes. © 2011 Wiley Periodicals, Inc. J Comput Chem, 2012

[1]  Ulf Ryde,et al.  Quantum refinement of [FeFe] hydrogenase indicates a dithiomethylamine ligand. , 2010, Journal of the American Chemical Society.

[2]  M. Gilson,et al.  Calculation of protein-ligand binding affinities. , 2007, Annual review of biophysics and biomolecular structure.

[3]  Gerhard Klebe,et al.  A fast and efficient method to generate biologically relevant conformations , 1994, J. Comput. Aided Mol. Des..

[4]  Kristina Nilsson,et al.  Quantum refinement - a combination of quantum chemistry and protein crystallography. , 2003 .

[5]  Xiao He,et al.  Conformational variability of benzamidinium-based inhibitors. , 2009, Journal of the American Chemical Society.

[6]  D. Moras,et al.  Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. , 2001, Journal of molecular biology.

[7]  P. Harbury,et al.  Design of protein-ligand binding based on the molecular-mechanics energy model. , 2008, Journal of molecular biology.

[8]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[9]  Kristina Nilsson,et al.  Quantum chemistry can locally improve protein crystal structures. , 2003, Journal of the American Chemical Society.

[10]  R. Pattanayek,et al.  Protein and ligand adaptation in a retinoic acid binding protein , 1999, Protein science : a publication of the Protein Society.

[11]  A Coda,et al.  Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. , 1995, Science.

[12]  Pierre Chambon,et al.  A human retinoic acid receptor which belongs to the family of nuclear receptors , 1987, Nature.

[13]  Babak Borhan,et al.  Protein design: reengineering cellular retinoic acid binding protein II into a rhodopsin protein mimic. , 2007, Journal of the American Chemical Society.

[14]  L. D. De Luca,et al.  Therapeutic potential of "rexinoids" in cancer prevention and treatment. , 2009, Cancer research.

[15]  Jean-Paul Renaud,et al.  All-trans retinoic acid is a ligand for the orphan nuclear receptor RORβ , 2003, Nature Structural Biology.

[16]  Xue Li,et al.  Accurate assessment of the strain energy in a protein‐bound drug using QM/MM X‐ray refinement and converged quantum chemistry , 2011, J. Comput. Chem..

[17]  Kenneth M Merz,et al.  Critical assessment of quantum mechanics based energy restraints in protein crystal structure refinement , 2006, Protein science : a publication of the Protein Society.

[18]  T J Oldfield,et al.  X-LIGAND: an application for the automated addition of flexible ligands into electron density. , 2001, Acta crystallographica. Section D, Biological crystallography.

[19]  M. Gilson,et al.  Ligand configurational entropy and protein binding , 2007, Proceedings of the National Academy of Sciences.

[20]  A. Budhu,et al.  Direct Channeling of Retinoic Acid between Cellular Retinoic Acid-Binding Protein II and Retinoic Acid Receptor Sensitizes Mammary Carcinoma Cells to Retinoic Acid-Induced Growth Arrest , 2002, Molecular and Cellular Biology.

[21]  Steven W Muchmore,et al.  Crystallography, NMR and virtual screening: integrated tools for drug discovery. , 2003, Current opinion in drug discovery & development.

[22]  V S Lamzin,et al.  Modelling bound ligands in protein crystal structures. , 2004, Acta crystallographica. Section D, Biological crystallography.

[23]  Marcel L Verdonk,et al.  Automated Protein–Ligand Crystallography for Structure‐Based Drug Design , 2006, ChemMedChem.

[24]  Giuseppe Zanotti,et al.  Crystallographic studies on complexes between retinoids and plasma retinol-binding protein. , 1994 .

[25]  Warren J. Hehre,et al.  Practical strategies for electronic structure calculations , 1995 .

[26]  Jean-Paul Renaud,et al.  Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid , 1995, Nature.

[27]  Lindsay Sawyer,et al.  The ligand-binding site of bovine beta-lactoglobulin: evidence for a function? , 2002, Journal of molecular biology.

[28]  Julian Tirado-Rives,et al.  Contribution of conformer focusing to the uncertainty in predicting free energies for protein-ligand binding. , 2006, Journal of medicinal chemistry.

[29]  Kristina Nilsson,et al.  Quantum refinement — a method to determine protonation and oxidation states of metal sites in protein crystal structures , 2003 .

[30]  M. Newcomer,et al.  X-ray crystallographic identification of a protein-binding site for both all-trans- and 9-cis-retinoic acid. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Warren J. Hehre,et al.  AB INITIO Molecular Orbital Theory , 1986 .

[32]  Eamonn F. Healy,et al.  Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model , 1985 .

[33]  Jonas Boström,et al.  Reproducing the conformations of protein-bound ligands: A critical evaluation of several popular conformational searching tools , 2001, J. Comput. Aided Mol. Des..

[34]  Gerhard Klebe,et al.  What Can We Learn from Molecular Recognition in Protein–Ligand Complexes for the Design of New Drugs? , 1996 .

[35]  Babak Borhan,et al.  Structural analysis of site-directed mutants of cellular retinoic acid-binding protein II addresses the relationship between structural integrity and ligand binding. , 2008, Acta crystallographica. Section D, Biological crystallography.

[36]  Paul Tempst,et al.  Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR7 and RXRa , 1994 .

[37]  Kristina Nilsson,et al.  Quantum chemical geometry optimizations in proteins using crystallographic raw data , 2002, J. Comput. Chem..

[38]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[39]  Gerard J Kleywegt,et al.  Pound-wise but penny-foolish: How well do micromolecules fare in macromolecular refinement? , 2003, Structure.

[40]  Eric F. Johnson,et al.  Determinants of Cytochrome P450 2C8 Substrate Binding , 2008, Journal of Biological Chemistry.

[41]  Richard A Friesner,et al.  Modeling Polarization in Proteins and Protein-ligand Complexes: Methods and Preliminary Results. , 2005, Advances in protein chemistry.

[42]  V. Vivat-Hannah,et al.  Selective retinoids and rexinoids in cancer therapy and chemoprevention. , 2002, Drug discovery today.

[43]  K. Merz,et al.  Large-scale validation of a quantum mechanics based scoring function: predicting the binding affinity and the binding mode of a diverse set of protein-ligand complexes. , 2005, Journal of medicinal chemistry.

[44]  Kenneth M Merz,et al.  QM/MM X-ray refinement of zinc metalloenzymes. , 2010, Journal of inorganic biochemistry.

[45]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[46]  P. Charifson,et al.  Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding. , 2004, Journal of medicinal chemistry.

[47]  Gerard J Kleywegt,et al.  Application and limitations of X-ray crystallographic data in structure-based ligand and drug design. , 2003, Angewandte Chemie.

[48]  G. Malpeli,et al.  Crystal structure of the transthyretin--retinoic-acid complex. , 1995, European journal of biochemistry.

[49]  Gregor Eichele,et al.  Identification and spatial distribution of retinoids in the developing chick limb bud , 1987, Nature.

[50]  Gerhard Klebe,et al.  Toward a more efficient handling of conformational flexibility in computer-assisted modelling of drug molecules , 1995 .

[51]  M. Lambert,et al.  Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix. , 2000, Genes & development.

[52]  Stefan Schmitt,et al.  Do structurally similar ligands bind in a similar fashion? , 2006, Journal of medicinal chemistry.

[53]  K. Dill,et al.  Predicting absolute ligand binding free energies to a simple model site. , 2007, Journal of molecular biology.

[54]  Philippe Kastner,et al.  Nonsteroid nuclear receptors: What Are genetic studies telling us about their role in real life? , 1995, Cell.

[55]  P Chambon,et al.  Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Babak Borhan,et al.  The structure of Apo-wild-type cellular retinoic acid binding protein II at 1.4 A and its relationship to ligand binding and nuclear translocation. , 2006, Journal of molecular biology.

[57]  A. Brunger Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. , 1992 .

[58]  Kenneth M Merz,et al.  Refinement of protein crystal structures using energy restraints derived from linear-scaling quantum mechanics. , 2005, Acta crystallographica. Section D, Biological crystallography.

[59]  D. Moras,et al.  Structural basis for isotype selectivity of the human retinoic acid nuclear receptor. , 2000, Journal of molecular biology.

[60]  Peter A. Kollman,et al.  Calculation of molecular geometries, relative conformational energies, dipole moments, and molecular electrostatic potential fitted charges of small organic molecules of biochemical interest by density functional theory , 1995, J. Comput. Chem..

[61]  Cen Gao,et al.  Accounting for ligand conformational restriction in calculations of protein-ligand binding affinities. , 2010, Biophysical journal.

[62]  T. A. Jones,et al.  Crystal structures of cellular retinoic acid binding proteins I and II in complex with all-trans-retinoic acid and a synthetic retinoid. , 1995, Structure.

[63]  K. Umesono,et al.  Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Ilme Schlichting,et al.  Crystal structures of substrate-free and retinoic acid-bound cyanobacterial cytochrome P450 CYP120A1. , 2008, Biochemistry.